JB Chemicals Valuation
| JBCHEPHARM | 1,746 24.00 1.39% |
At this time, the entity appears to be overvalued. JB Chemicals Pharmac owns a latest Real Value of USD1519.02 per share. The recent price of the entity is USD1746.0. Our model calculates the value of JB Chemicals Pharmac from inspecting the entity fundamentals such as Return On Asset of 0.13, operating margin of 0.23 %, and Shares Owned By Insiders of 54.09 % as well as reviewing its technical indicators and probability of bankruptcy.
Price Book 8.3315 | Enterprise Value 264.3 B | Enterprise Value Ebitda 26.1333 | Price Sales 7.3206 | Forward PE 21.692 |
Overvalued
Today
Please note that JB Chemicals' price fluctuation is very steady at this time. Calculation of the real value of JB Chemicals Pharmac is based on 3 months time horizon. Increasing JB Chemicals' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since JB Chemicals is currently traded on the exchange, buyers and sellers on that exchange determine the market value of JBCHEPHARM Stock. However, JB Chemicals' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1746.0 | Real 1519.02 | Hype 1755.71 | Naive 1744.38 |
The intrinsic value of JB Chemicals' stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence JB Chemicals' stock price.
Estimating the potential upside or downside of JB Chemicals Pharmaceuticals helps investors to forecast how JBCHEPHARM stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of JB Chemicals more accurately as focusing exclusively on JB Chemicals' fundamentals will not take into account other important factors: JB Chemicals Cash |
|
JB Chemicals Total Value Analysis
JB Chemicals Pharmaceuticals is currently forecasted to have takeover price of 264.28 B with market capitalization of 271.69 B, debt of 3.78 B, and cash on hands of 269.12 M. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the JB Chemicals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
264.28 B | 271.69 B | 3.78 B | 269.12 M |
JB Chemicals Investor Information
About 54.0% of the company shares are held by company insiders. The company recorded earning per share (EPS) of 38.35. JB Chemicals Pharmac last dividend was issued on the 14th of August 2024. The entity had 2:1 split on the 18th of September 2023. Based on the key indicators related to JB Chemicals' liquidity, profitability, solvency, and operating efficiency, JB Chemicals Pharmaceuticals is performing exceptionally good at this time. It has a great probability to report excellent financial results in March.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Income | 9.1 B | 8.7 B |
|
|
JB Chemicals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. JB Chemicals has an asset utilization ratio of 86.32 percent. This signifies that the Company is making USD0.86 for each dollar of assets. An increasing asset utilization means that JB Chemicals Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.JB Chemicals Ownership Allocation
JB Chemicals Pharmac secures a total of 155.61 Million outstanding shares. JB Chemicals Pharmac shows tangible amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company retains, if the real value of the entity is less than the current market value, you may not be able to make money on it.JB Chemicals Profitability Analysis
The company reported the revenue of 34.48 B. Net Income was 5.53 B with profit before overhead, payroll, taxes, and interest of 24.27 B.About JB Chemicals Valuation
An absolute valuation paradigm, as applied to JBCHEPHARM Stock, attempts to find the value of JB Chemicals Pharmac based on its fundamental and basic technical indicators. By analyzing JB Chemicals's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of JB Chemicals's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of JB Chemicals. We calculate exposure to JB Chemicals's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of JB Chemicals's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 15.2 B | 9.7 B |
JB Chemicals Quarterly Retained Earnings |
|
Complementary Tools for JBCHEPHARM Stock analysis
When running JB Chemicals' price analysis, check to measure JB Chemicals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy JB Chemicals is operating at the current time. Most of JB Chemicals' value examination focuses on studying past and present price action to predict the probability of JB Chemicals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move JB Chemicals' price. Additionally, you may evaluate how the addition of JB Chemicals to your portfolios can decrease your overall portfolio volatility.
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Fundamental Analysis View fundamental data based on most recent published financial statements |